MedTrace Logo

Lung Cancer Screening of Family Members of Patients With Mutation-Driven Lung Cancer

NCT07062172 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1753

Last updated 2025-07-14

No results posted yet for this study

Summary

This is a single-armed screening research study which screens immediate family member of lung cancer patients with a driver mutation to see if lung cancer can be inherited and whether researchers can find lung cancer early. Immediate family members of lung cancer patients will be 40-80 years old and screened using a low dose CT scan.

Conditions

Interventions

DIAGNOSTIC_TEST

Low Dose CT Scan

Completed once after screening and eligibility is confirmed.

Sponsors & Collaborators

  • University of California, Irvine

    lead OTHER

Study Design

Allocation
NA
Purpose
SCREENING
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-05-08
Primary Completion
2027-12-31
Completion
2028-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07062172 on ClinicalTrials.gov